A) about to pop Or B) bubbly as ever ???
anonymous Guest anonymous Jul 16, 2024 at 01:54: PM #1 anonymous Guest A) about to pop Or B) bubbly as ever ???
anonymous Guest anonymous Jul 31, 2024 at 02:21: PM #2 anonymous Guest It is somewhere in-between A and B. Good biotech drugs aimed at large indications that are Phase II/III or entering the market for large indications will do OK. Niche drugs and those that are preclinical will have a hard time staying funded.
It is somewhere in-between A and B. Good biotech drugs aimed at large indications that are Phase II/III or entering the market for large indications will do OK. Niche drugs and those that are preclinical will have a hard time staying funded.
